symbol,statement_type,period_end,line_item,value
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Normalized EBITDA,694000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Total Unusual Items,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,611000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,15867100000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,EBITDA,694000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,EBIT,83000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Interest Income,-491500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Interest Expense,491500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Interest Income,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Normalized Income,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Total Expenses,20618100000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Diluted Average Shares,102444444.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Basic Average Shares,102444444.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Diluted EPS,-4.5
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Basic EPS,-4.5
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,-461000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Tax Provision,52500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Pretax Income,-408500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,206000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Special Income Charges,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Other Special Charges,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-491500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,491500000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Operating Income,-123000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Operating Expense,4751000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Other Operating Expenses,3255300000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,611000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Amortization,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,611000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Research And Development,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Selling General And Administration,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Gross Profit,4628000000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Cost Of Revenue,15867100000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Total Revenue,20495100000.0
TIRUMALCHM.NS,income,2025-03-31 00:00:00,Operating Revenue,20495100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Normalized EBITDA,703600000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Total Unusual Items,3700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,3700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,632000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,16640200000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,EBITDA,703600000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,EBIT,71600000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Interest Income,-417100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Interest Expense,417100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Interest Income,105700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Normalized Income,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Total Expenses,20953100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,37000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Diluted Average Shares,102348285.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Basic Average Shares,102348285.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Diluted EPS,-3.79
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Basic EPS,-3.79
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-387900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Tax Provision,42400000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Pretax Income,-345500000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,193400000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Special Income Charges,3700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Other Special Charges,-3700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-417100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,58200000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,417100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,105700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Operating Income,-121800000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Operating Expense,4312900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2882700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,632000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Amortization,1000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,632000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Research And Development,24700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Selling General And Administration,1205700000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,1033800000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,General And Administrative Expense,171900000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,37000000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Gross Profit,4191100000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Cost Of Revenue,16640200000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Total Revenue,20831300000.0
TIRUMALCHM.NS,income,2024-03-31 00:00:00,Operating Revenue,20831300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,3120180.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.3059
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Normalized EBITDA,2102700000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Total Unusual Items,10200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,10200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,556800000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,15589000000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,EBITDA,2112900000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,EBIT,1556100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Interest Income,-147300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Interest Expense,262000000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Interest Income,165200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Normalized Income,891220180.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Total Expenses,19895100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,36800000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Diluted Average Shares,102388120.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Basic Average Shares,102388120.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Diluted EPS,8.77
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Basic EPS,8.77
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,898300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Tax Provision,395800000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Pretax Income,1294100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,10700000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Special Income Charges,10500000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Other Special Charges,-10500000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-147300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,50500000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,262000000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,165200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Operating Income,1308200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Operating Expense,4306100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Other Operating Expenses,1610200000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,556800000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Amortization,700000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,556100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Research And Development,25300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Selling General And Administration,1377100000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,1182500000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,General And Administrative Expense,194600000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,36800000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Gross Profit,5614300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Cost Of Revenue,15589000000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Total Revenue,21203300000.0
TIRUMALCHM.NS,income,2023-03-31 00:00:00,Operating Revenue,21203300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-50480.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.2524
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Normalized EBITDA,4489300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Total Unusual Items,-200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,566300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,12146400000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,EBITDA,4489100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,EBIT,3922800000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Interest Income,-153100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Interest Expense,169100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Interest Income,50600000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Normalized Income,2812449520.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Total Expenses,16010200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,24000000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Diluted Average Shares,102388120.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Basic Average Shares,102388120.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Diluted EPS,27.46
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Basic EPS,27.46
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,2812300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Tax Provision,941400000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Pretax Income,3753700000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,11200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Special Income Charges,1000000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Other Special Charges,-1000000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-153100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,34600000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,169100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,50600000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Operating Income,3873500000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Operating Expense,3863800000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Other Operating Expenses,1108200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,566300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Amortization,1200000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,565100000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Research And Development,26400000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Selling General And Administration,1462900000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,1350600000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,General And Administrative Expense,112300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,24000000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Gross Profit,7737300000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Cost Of Revenue,12146400000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Total Revenue,19883700000.0
TIRUMALCHM.NS,income,2022-03-31 00:00:00,Operating Revenue,19883700000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Total Unusual Items,9700000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,9700000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,EBITDA,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,EBIT,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Interest Income,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Interest Expense,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Interest Income,45900000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Normalized Income,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Total Expenses,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,20100000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Basic Average Shares,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Diluted EPS,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Basic EPS,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Tax Provision,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Pretax Income,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Special Income Charges,9300000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Other Special Charges,-9300000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,31100000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,45900000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Operating Income,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Operating Expense,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Amortization,2300000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Research And Development,29000000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Selling General And Administration,778200000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,683200000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,General And Administrative Expense,95000000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,20100000.0
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Gross Profit,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Total Revenue,
TIRUMALCHM.NS,income,2021-03-31 00:00:00,Operating Revenue,
